Rapidly progressive muscle weakness in anti-myelin associated glycoprotein (MAG) neuropathy successfully treated with intravenous immunoglobulin
Anti-myelin associated glycoprotein (MAG) neuropathy typically progresses slowly, but rare cases exhibit rapid deterioration. We report an 83-year-old man with a two-year history of paresthesia in both feet and recent-onset gait ataxia who developed rapidly progressive muscle weakness in all four limbs over several days. Nerve conduction studies and positive anti-MAG antibodies confirmed the diagnosis of anti-MAG neuropathy. The patient's muscle weakness improved with intravenous immunoglobulin (IVIg) therapy. This case highlights the existence of atypical anti-MAG neuropathy mimicking chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with a rapid deterioration course and suggests the potential efficacy of IVIg in such presentations.
Authors
- Akihiko Ozaki (ORCID: https://orcid.org/0000-0003-4415-9657)
- Mari Fukuda (ORCID: https://orcid.org/0000-0001-6049-0046)
- Keigo Ikeda (ORCID: https://orcid.org/0000-0002-8032-7147)
- Kentaro Yamakawa
- Yohei Takenobu
Institutions
- Kyoto University (JP)
- Osaka Hospital (JP)
- Japan Community Healthcare Organization (JP)
- Kobe University (JP)
Publication Details
- Journal
- Rinsho Shinkeigaku
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5692/clinicalneurol.cn-002030
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00